# Febuxostat

NDC: 0054-0413
Generic name: Febuxostat
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191111

FDA application: ANDA205414

## Active ingredients

- FEBUXOSTAT: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0413"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0413
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=14f1555c-2565-42c7-b3f5-dd5f03fed67a